摘要
新型免疫抑制剂在降低急性排斥反应发生率的同时，也因其狭窄的治疗指数以及药代动力学、药效动力学的个体差异而导致的药物毒性，很大程度上影响了移植物以及受者的长期存活。
出处
《中华器官移植杂志》
CAS
CSCD
北大核心
2011年第9期513-515,共3页
Chinese Journal of Organ Transplantation
参考文献19
-
1Midtvedt K, Fauchald P, Bergan S, et al. C2 monitoring in maintenance renal transplant recipients: is it worthwhile? Transplantation, 2003,76 ( 8 ) : 1236-1238.
-
2Eineeke G, Mai I, Fritsche L, et al. The value of C2 monitoring in stable renal allograft recipients on maintenance immunosuppression. Nephrol Dial Transplant, 2004, 19 ( 1 ) : 215-222.
-
3Levy G, Burra P, Cavallari A, et al. Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2). Transplantation, 2002,73(6):953-959.
-
4Undre NA. Pharmacokinetics of tacrolimus-based combination therapies. Nephrol Dial Transplant,2003,18 Suppl 1 :S12-15.
-
5Chisholm MA, Middleton MD. Modified-release taerolimus. Ann Pharmacother, 2006,40 (2): 270-275.
-
6van Gelder T, Le Meur Y, Shaw LM, et al. Therapeutic drug monitoring of mycophenolate mofetil in transplantation. Ther Drug Monit, 2006,28 ( 2 ) : 145-154.
-
7Thervet E, Anglicheau D, King B, et al. Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients. Transplantation, 2003,76(8): 1233-1235.
-
8Kuypers DR, de Jonge H, Naesens M, et al. CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients. Clin Pharmacol Ther, 2007, 82(6) :711-725.
-
9Miao LY, Huang CR, Hou JQ, et al. Association study of ABCB1 and CYP3A5 gene polymorphisms with sirolimus trough concentration and dose requirements in Chinese renal transplant recipients. Biopharm Drug Dispos, 2008,29 ( 1 ): 1-5.
-
10Renders L, Frisman M, Ufer M, et al. CYP3A5 genotype markedly influences the pharmacokinetics of taerolimns and sirolimus in kidney transplant recipients. Clin Pharmacol Ther, 2007,81 (2) : 228-234.
-
1孙显军.中药内服加保留灌肠治疗慢性非特异性结肠炎33例疗效观察[J].河北医学,2013,19(1):147-148. 被引量：7
-
2李文英.温针灸联合补脾益肠丸治疗慢性溃疡性结肠炎脾肾亏虚型临床疗效观察[J].中医药信息,2014,31(6):87-89. 被引量：14
-
3王蕾,王国华.女性免疫性不孕的中药治疗体会[J].中国临床医生杂志,2007,35(2):59-60.
-
4黄永昌.胃癌长期存活案例分析及有关问题探讨[J].吉林中医药,1993,13(1):31-31. 被引量：3
-
5张晓星,王萌嘉,李莉,王丽哲.保肝II号治疗自身免疫性肝炎的临床观察[J].中国卫生标准管理,2015,6(29):140-141. 被引量：1
-
6巩路.关注风湿病患者治疗中机会性感染的防治[J].中华风湿病学杂志,2011,15(1):1-2. 被引量：2
-
7雷海燕.滋肾解毒化瘀汤治疗系统性红斑狼疮效果观察[J].中药材,2007,30(9):1201-1202. 被引量：3
-
8胡明亮,苏明,姜松青,石晓峰,孙明.肾移植术后并发肺孢子菌肺炎四例报告[J].中国呼吸与危重监护杂志,2006,5(3):210-211. 被引量：2
-
9李成婷,许小凤.中西医治疗卵巢早衰研究进展[J].河南中医,2014,34(6):1157-1158. 被引量：5
-
10李士林,张燕,于晓宏,王宁.补肾化瘀法治疗环孢素A引发肝损害16例[J].山东中医药大学学报,2001,25(1):36-36.
